Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003315059 | SCV004014566 | uncertain significance | not provided | 2023-01-17 | criteria provided, single submitter | clinical testing | Reported in a patient with polycystic kidney disease in published literature (Raj et al., 2017); clinical information not provided; In silico analysis supports that this variant does not alter splicing; This variant is associated with the following publications: (PMID: 29321346) |
3billion | RCV005254762 | SCV005904728 | uncertain significance | Polycystic kidney disease 2 | 2023-06-29 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.003%). Predicted Consequence/Location: Intron variant The variant has been reported to be associated with PKD2 related disorder (PMID: 29321346). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline. |
Prevention |
RCV003928983 | SCV004745256 | likely benign | PKD2-related disorder | 2019-09-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |